17 of 238 unique stocks in common · Jaccard: 7.1%
A weighted portfolio overlap of 21.09% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹21.09 is allocated to the exact same companies at the same relative proportions. The schemes share 17 common holdings.
The largest overlapping asset in their portfolios is Infosys, which commands a weight of 3.61% in UTI Nifty 50 Index Fund and 6.48% in UTI Nifty500 Shariah Index Fund. Holding both schemes increases your concentration in Infosys rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in UTI Nifty | in UTI Nifty500 |
|---|---|---|
| InfosysIT - Software | 3.61% | 6.48% |
| Tata Consultancy ServicesIT - Software | 2.22% | 3.99% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 1.91% | 3.43% |
| Hindustan UnileverDiversified FMCG | 1.58% | 2.85% |
| Hindalco IndustriesNon - Ferrous Metals | 1.33% | 2.40% |
| HCL TechnologiesIT - Software | 1.26% | 2.26% |
| Ultratech CementCement & Cement Products | 1.23% | 2.21% |
| Asian PaintsConsumer Durables | 1.09% | 1.96% |
| Nestle IndiaFood Products | 0.97% | 1.75% |
| Tech MahindraIT - Software | 0.94% | 1.69% |
| TrentRetailing | 0.87% | 1.56% |
| Oil & Natural Gas CorporationOil | 0.82% | 1.47% |
| CiplaPharmaceuticals & Biotechnology | 0.72% | 1.29% |
| Max Healthcare InstituteHealthcare Services | 0.70% | 1.26% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 0.64% | 1.15% |
| Tata Consumer ProductsAgricultural Food & Other Products | 0.61% | 1.10% |
| Tata Motors Passenger VehiclesAutomobiles | 0.59% | 1.05% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.